Drug Shortage Report for ZANTAC

Last updated on 2020-02-27 History
Report ID 2751
Drug Identification Number 02212366
Brand name ZANTAC
Common or Proper name Ranitidine injection
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL x 10's
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2016-04-25
Estimated end date
Actual end date 2018-08-31
Shortage status Resolved
Updated date 2020-02-27
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-02-27 French Compare
v13 2020-02-27 English Compare
v12 2017-09-18 French Compare
v11 2017-09-18 English Compare
v10 2017-04-05 French Compare
v9 2017-04-05 English Compare
v8 2017-03-24 French Compare
v7 2017-03-24 French Compare
v6 2017-03-24 English Compare
v5 2017-03-24 English Compare
v4 2017-03-17 French Compare
v3 2017-03-17 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 14 of 14